P1005 (DAIDS ID 10314): A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1-Infected Children

Study Status Study Restriction


Not Applicable

Sites where the study was implemented:

CRS ID Site Name City Country


UCSD Mother-Child-Adolescent HIV Program

San Diego

United States of America


Boston Medical Center Pediatric HIV Program


United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center


Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.